Medication info
Ibuprofen Tablet 500 mg

Ibuprofen Tablet 500 mg

Prescription medicationTabletOral
Ingredient · strength
Nabumetone›500mg
Manufacturer / importer
Teragen Inc.
Appearance
[For domestic use] Yellow oval film-coated tablets
Packaging
For domestic use - 30 tablets/bottle, For domestic use - 500 tablets/bottle
Approval status
Active

MFDS item code 200411208 · Notified 2004.09.09 · Insurance code 698500350

Summary

Main use
Relieves inflammation and pain associated with arthritis (osteoarthritis and rheumatoid arthritis)
Who takes it
Adults · Children
Adult dose
This medicine is for oral use. Swallow it without chewing (tablets only). Adults: Administer 1 g of nabumetone orally once daily at bedtime. If symptoms are severe or persistent, or worsen rapidly, an additional 500 mg∼1 g of this medicine may be administered orally in the morning. Older adults: As with many other medicines, plasma concentrations may be higher in older patients. Do not exceed a maximum daily dose of 1 g; in some cases, satisfactory symptom relief may be achieved with a dose of 500 mg.
Child dose
Children: Clinical data on the use of this product in children are not yet available.

Ingredients

Manufacturer
Teragen Inc.

Efficacy & effects

Relieves inflammation and pain associated with arthritis (osteoarthritis and rheumatoid arthritis)

  • Osteoarthritis
  • rheumatoid arthritis
View approved original text

This medicine is effective in relieving the inflammation and pain associated with osteoarthritis and rheumatoid arthritis. It helps reduce joint inflammation and alleviates pain, allowing for a more comfortable daily life. It also contributes to improved joint function, making movement more comfortable. Due to these characteristics, it is used to improve the symptoms of osteoarthritis and rheumatoid arthritis.

How to take

Adult dose

This medicine is for oral use. Swallow it without chewing (tablets only). Adults: Administer 1 g of nabumetone orally once daily at bedtime. If symptoms are severe or persistent, or worsen rapidly, an additional 500 mg∼1 g of this medicine may be administered orally in the morning. Older adults: As with many other medicines, plasma concentrations may be higher in older patients. Do not exceed a maximum daily dose of 1 g; in some cases, satisfactory symptom relief may be achieved with a dose of 500 mg.

Child dose

Children: Clinical data on the use of this product in children are not yet available.

Precautions

This medication can cause a risk of gastrointestinal bleeding in individuals who regularly consume more than three glasses of alcohol daily, so consultation with a doctor or pharmacist is essential. This medication can affect the cardiovascular system, potentially increasing the risk of serious cardiovascular issues such as myocardial infarction or stroke. Individuals with cardiovascular disease or risk factors should be particularly cautious and closely monitor for any cardiovascular symptoms during treatment. Additionally, this medication can lead to serious gastrointestinal issues such as bleeding, ulcers, and perforations, especially in the elderly or those with a history of gastrointestinal diseases, necessitating the starting of the lowest dose and careful monitoring. Patients with peptic ulcers, severe blood disorders, liver disorders, kidney disorders, heart disorders, those with hypersensitivity to this medication, and asthmatics should not take this medication. Individuals with blood disorders, liver disorders, kidney disorders, heart disorders, a history of allergic reactions, asthma, hypertension, heart failure, autoimmune diseases, and elderly patients should take this medication with caution and consult a doctor for appropriate measures if necessary. Side effects such as shock, anaphylaxis, skin rashes, gastrointestinal disturbances, liver dysfunction, kidney damage, breathing difficulties, and blood abnormalities may occur. If abnormal symptoms arise, discontinue use immediately and consult medical personnel. This medication may interact with other non-steroidal anti-inflammatory drugs (NSAIDs) or various medications, so it is essential to inform a doctor or pharmacist of any other medications being taken. Pregnant or potentially pregnant women and nursing mothers should avoid taking this medication, and it is also advisable to avoid use in children and adolescents under 15. Elderly patients have a higher risk of gastrointestinal bleeding; therefore, it is essential to start at the lowest dose and closely monitor gastrointestinal conditions during the first four weeks of treatment. In case of overdose, symptoms may include headache, nausea, vomiting, gastrointestinal bleeding, dizziness, and coma. As no specific antidote exists, immediate medical attention is required. This medication should be kept out of reach of children and not transferred to another container to maintain its quality.

Side effects

Shock, anaphylaxis-like symptoms, difficulty breathing, hives, hypotension, angioedema, facial swelling, rash, itching, dyspepsia, abdominal pain, upper abdominal discomfort, epigastric pain, abdominal distension, loss of appetite, nausea, vomiting, hematemesis, diarrhea, constipation, air retention in the gastrointestinal tract, gastritis, peptic ulcer, perforation, gastrointestinal bleeding, gastrointestinal disorders, hematochezia, melena, ulcerative colitis, onset or exacerbation of Crohn's disease, pancreatitis, stomatitis, dry mouth, dizziness, headache, confusion, fear, irritability, increased tension, insomnia, drowsiness, sensory disturbances, elevated AST, elevated ALT, elevated AL-P, liver failure, hepatitis, jaundice, nephrotic syndrome, kidney failure, urinary disorders, interstitial nephritis, acute tubular necrosis, papillary necrosis, increased urinary protein, elevated BUN, increased serum creatinine, interstitial pneumonia, respiratory distress, bronchospasm, asthma, nosebleeds, vascular edema, false porphyria, hair loss, polyform rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, sweating, photosensitivity reaction, thrombocytopenia, neutropenia, agranulocytosis, leukopenia, leukemia, aplastic anemia, hemolytic anemia, vasculitis, hypertension, heart failure, myopathy, neck stiffness, uterine bleeding, menorrhagia, tinnitus, ear disorders, abnormal vision, visual impairment, optic neuritis, edema, fatigue, weakness, aseptic meningitis, headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, diarrhea, disorientation, agitation, coma, dizziness, tinnitus, fainting, seizures, acute kidney failure, liver damage

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container and kept at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

[For domestic use] Yellow oval film-coated tablets

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.